We observed enrichment in disease ontologies relating to acquired metabolic disease, glucose metabolism disease, diabetes mellitus, carbohydrate metabolism disease, disease of metabolism, and clustering around genes including CXCL5, EGF, and SPARC (Fig. 1c–g). This evidence concerns the gene EGF and acquired metabolic disease.